Profil
Seth Reno worked as Head-Commercial Operations at MedImmune LLC from 2010 to 2015.
He also worked as Chief Commercial Officer at Gemphire Therapeutics, Inc. and NeuroBo Pharmaceuticals, Inc. Mr. Reno holds an MBA from Strayer University and an undergraduate degree from the University of Delaware.
Anciens postes connus de Seth Reno
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/04/2015 |
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Seth Reno
| University of Delaware | Undergraduate Degree |
| Strayer University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
